Published in Open Forum Infect Dis on September 25, 2015
Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen. Front Microbiol (2016) 0.79
In Vitro Antifungal Activity of Sertraline and Synergistic Effects in Combination with Antifungal Drugs against Planktonic Forms and Biofilms of Clinical Trichosporon asahii Isolates. PLoS One (2016) 0.75
Purpuric and cream-colored plaques in an immunocompromised person: A case of disseminated trichosporonosis. JAAD Case Rep (2016) 0.75
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
Emerging opportunistic yeast infections. Lancet Infect Dis (2011) 3.27
Early removal of central venous catheter in patients with candidemia does not improve outcome: analysis of 842 patients from 2 randomized clinical trials. Clin Infect Dis (2010) 3.07
Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol (1990) 2.99
Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother (2005) 2.62
Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J Clin Microbiol (1999) 2.48
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol (2005) 2.45
Contributions to a revision of the genus Trichosporon. Antonie Van Leeuwenhoek (1992) 2.14
Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) (1986) 2.11
Current knowledge of Trichosporon spp. and Trichosporonosis. Clin Microbiol Rev (2011) 2.08
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect (2014) 2.06
Emerging fungal diseases. Clin Infect Dis (2005) 2.03
In vitro antifungal susceptibilities of Trichosporon species. Antimicrob Agents Chemother (2002) 2.03
Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis (2009) 1.96
Trichosporon on humans: a practical account. Mycoses (1994) 1.90
Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect (2011) 1.90
Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis (2002) 1.85
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol (2001) 1.52
Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections. J Antimicrob Chemother (2012) 1.50
Neotypification of the genus Trichosporon. Antonie Van Leeuwenhoek (1992) 1.46
Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect (2007) 1.43
Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients. J Clin Microbiol (1995) 1.35
Trichosporon species infection in bone marrow transplanted patients. Diagn Microbiol Infect Dis (2001) 1.33
Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis (2003) 1.33
Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Eur J Clin Microbiol Infect Dis (2002) 1.30
Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J Infect Dis (1992) 1.30
Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol (2009) 1.29
Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review. Clin Infect Dis (1992) 1.23
Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin Infect Dis (2006) 1.21
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole. J Clin Microbiol (2003) 1.20
Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur J Haematol (2010) 1.18
Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis (2004) 1.17
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother (2006) 1.16
Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review. Eur J Clin Microbiol Infect Dis (1994) 1.14
Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother (1994) 1.13
Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J Med Microbiol (2005) 1.09
Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality. J Hosp Infect (2005) 1.08
Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer (1999) 1.04
Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts. Bone Marrow Transplant (2000) 1.01
Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol (2003) 1.00
In vitro combined activity of amphotericin B, caspofungin and voriconazole against clinical isolates of Trichosporon asahii. Int J Antimicrob Agents (2010) 0.99
Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection (2007) 0.99
Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol (2009) 0.95
Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B. Transpl Infect Dis (2011) 0.92
A prospective cohort study evaluating the prognostic impact of clinical characteristics and comorbid conditions of hospitalized adult and pediatric cancer patients with candidemia. Eur J Clin Microbiol Infect Dis (2008) 0.90
A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. Clin Microbiol Infect (2013) 0.88
Fatal invasive trichosporonosis due to Trichosporon loubieri in a patient with T-lymphoblastic lymphoma. Med Mycol (2010) 0.87
Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors. Mycoses (2005) 0.87
Bloodstream infection due to Trichosporon beigelii in a burn patient: case report and review of therapy. Clin Infect Dis (1995) 0.87
Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen. J Infect Dis (1994) 0.85
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis. Antimicrob Agents Chemother (2006) 0.84
Successful treatment of a Trichosporon beigelii septicemia in a granulocytopenic patient with amphotericin B and granulocyte colony-stimulating factor. Infection (1995) 0.83
Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy. Mycoses (2011) 0.83
Antifungal pharmacodynamic characteristics of amphotericin B against Trichosporon asahii, using time-kill methodology. Microbiol Immunol (2002) 0.82
Candidemia in cancer patients: impact of early removal of non-tunneled central venous catheters on outcome. J Infect (2009) 0.81
Breakthrough trichosporonosis in patients receiving echinocandins: case report and literature review. Chin Med J (Engl) (2012) 0.81
On and Under the Skin: Emerging Basidiomycetous Yeast Infections Caused by Trichosporon Species. PLoS Pathog (2015) 0.80
Fungemia in non-HIV-infected patients: a five-year review. Int J Infect Dis (2008) 0.80
Clinical characteristics and risk factors of non-Candida fungaemia. BMC Infect Dis (2013) 0.80
In vitro activities of antifungal combinations against biofilms and planktonic forms of clinical Trichosporon asahii isolates. Antimicrob Agents Chemother (2014) 0.80
Uncommon yeast infections in hematological patients: from diagnosis to treatment. Expert Rev Anti Infect Ther (2011) 0.79
Improving survival of patients with candidaemia: analysis of prognostic factors from a long-term, nationwide study in Iceland. Scand J Infect Dis (2005) 0.78
Efficacy of Ethanol against Trichosporon asahii Biofilm in vitro. Med Mycol (2015) 0.78
Trichosporon beigelii fungemia in patients with acute leukemia: report of three cases. J Formos Med Assoc (1995) 0.77
Development of a loop-mediated isothermal amplification assay for rapid detection of Trichosporon asahii in experimental and clinical samples. Biomed Res Int (2015) 0.76